Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity.

Peng B, Voltan R, Cristillo AD, Alvord WG, Davis-Warren A, Zhou Q, Murthy KK, Robert-Guroff M.

AIDS. 2006 Nov 14;20(17):2149-57.

PMID:
17086054
2.

Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.

Zhao J, Voltan R, Peng B, Davis-Warren A, Kalyanaraman VS, Alvord WG, Aldrich K, Bernasconi D, Buttò S, Cafaro A, Ensoli B, Robert-Guroff M.

Virology. 2005 Nov 10;342(1):1-12. Epub 2005 Aug 18.

3.

Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies.

Peng B, Wang LR, Gómez-Román VR, Davis-Warren A, Montefiori DC, Kalyanaraman VS, Venzon D, Zhao J, Kan E, Rowell TJ, Murthy KK, Srivastava I, Barnett SW, Robert-Guroff M.

J Virol. 2005 Aug;79(16):10200-9.

4.

HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro.

D'Costa J, Harvey-White J, Qasba P, Limaye A, Kaneski CR, Davis-Warren A, Brady RO, Bankiewicz KS, Major EO, Arya SK.

J Med Virol. 2003 Oct;71(2):173-82.

PMID:
12938190
5.

Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.

D'Costa J, Brown H, Kundra P, Davis-Warren A, Arya S.

J Gen Virol. 2001 Feb;82(Pt 2):425-34.

PMID:
11161282
6.

In vitro phenotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo.

Arya SK, Ginsberg CC, Davis-Warren A, D'Costa J.

J Hum Virol. 1999 May-Jun;2(3):133-8.

PMID:
10413364

Supplemental Content

Loading ...
Support Center